U.S. Cannabis Market Faces First-Ever Revenue Decline

According to new forecasts from Whitney Economics, total U.S. cannabis revenue in 2025 is expected to land between $29.1 billion and $29.6 billion, falling below the $30.1 billion recorded in 2024. The projected 3.2% decrease marks a historic inflection point for an industry that has long been defined by rapid growth and expansion.

This forecast applies exclusively to regulated adult-use and medical cannabis sales, highlighting structural challenges within legal markets rather than shifts driven by illicit activity or unregulated hemp-derived products.

The downturn is not evenly distributed. Approximately 23 states are expected to experience year-over-year revenue declines in 2025, up from 17 states in 2024 and just 10 in 2023. The trend signals mounting pressure across mature markets, where oversupply, price compression, limited access to capital, and regulatory fragmentation continue to strain operators.

While much of the industry’s attention remains focused on federal scheduling discussions and hemp policy debates, the revenue outlook suggests deeper economic headwinds. Slowing consumer growth, margin erosion, and state-level market saturation are increasingly shaping the industry’s near-term trajectory.

As cannabis enters a more mature phase, the data underscores a critical shift: success will depend less on expansion and more on operational discipline, regulatory clarity, and sustainable business models.

For operators, investors, and policymakers alike, 2025 may mark the end of the industry’s growth-only era, and the beginning of a far more competitive and economically demanding chapter.

Photo by Ussama Azam on Unsplash